September 18, 2012 10:19 am by Staff | 0 Comments
(Reuters) - Biotechnology company Sarepta Therapeutics Inc said U.S. health regulators granted fast track status to two of its experimental drugs for the treatment of the Marburg and Ebola viruses.Shares ...
Read more